Treatment for stage 2 essential thrombocythemia is highly personalized. Not every patient requires medication right away, and ...

Iberdomide, combined with Darzalex and dexamethasone, improves MRD negativity in relapsed multiple myeloma, showcasing CELMoDs' potential in treatment. Early-stage blood cancer diagnosis and ...

Blood cancer treatment is entering a new era, bringing powerful breakthroughs that offer renewed hope to people living with leukemia, lymphoma, myeloma, and other blood cancers. Cutting-edge targeted ...

A Northwestern Medicine-led study published in the Journal of Clinical Investigation has uncovered why older individuals with specific genetic mutations face a heightened risk of developing serious ...

Multiple myeloma is a chronic (long-term) blood cancer that affects plasma cells made in the bone marrow, which is spongy tissue found inside bones. While people with multiple myeloma can live for ...

Researchers working on an incurable blood cancer can now use a new lab model that could make testing potential new treatments and diagnostics easier and quicker, new research has found. Working with ...

Researchers working on an incurable blood cancer can now use a new lab model which could make testing potential new treatments and diagnostics easier and quicker, new research has found. In a paper ...

More Americans diagnosed with cancer are now surviving the disease - marking a positive trend that experts say reflects the ...

Johns Hopkins University cancer researcher Mikala Egeblad has received the 2025 Ernst W. Bertner Memorial Award in ...